Hamm & Wittkopp patent opposition analysis

The comprehensive analysis of Hamm & Wittkopp opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Hamm & Wittkopp

Patent NumberTitleApplicantOpposition DateOpposition Company
Crystalline Solid Forms Of Salts Of N-{4-[(6,7-Dimethoxyquinolin-4-Yl) Oxy]Phenyl}-N'-(4-Fluorphenyl) Cyclopropane-1,1-Dicarboxamide, Processes For Making, And Methods Of UseEXELIXISSep 21, 2022STADA ARZNEIMITTEL
Pharmaceutical Composition Containing Rifaximin Alpha & DeltaSANDOZApr 6, 2022ALFRED E TIEFENBACHER
Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICA NVJan 22, 2021STADA ARZNEIMITTEL
Enterically Coated Cysteamine, Cystamine And Derivatives ThereofTHE REGENTS OF THE UNIVERSITY OF CALIFORNIASep 18, 2020ALFRED E TIEFENBACHER
Cabazitaxel And Its Use For Treating CancerAVENTIS PHARMASep 17, 2020STADA ARZNEIMITTEL
(+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione: Methods Of Using And Compositions ThereofCELGENEOct 16, 2019STADA ARZNEIMITTEL
Rapamycin Derivative For The Treatment Of A Solid Tumor Associated With Deregulated AngiogenesisNOVARTISMay 23, 2019STADA ARZNEIMITTEL
Method Of Increasing Bone Toughness And Stiffness And Reducing FracturesELI LILLYApr 27, 2018STADA ARZNEIMITTEL
Pharmaceutical Formulation Comprising EzetimibeASSIA CHEMICAL INDUSTRIES LTD.Apr 19, 2018WITTKOPP
Pharmaceutical Composition Having Desirable BioavailabilityALCON RESEARCHJan 26, 2018ALFRED E TIEFENBACHER